Trial Profile
SAM-e Treatment of Depression in Parkinson's Disease.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Ademetionine (Primary) ; Escitalopram
- Indications Depressive disorders
- Focus Therapeutic Use
- 22 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Dec 2009 Planned end date changed from 1 Oct 2009 to 1 Oct 2010 as reported by ClinicalTrials.gov.
- 01 Apr 2009 Planned number of patients changed from 100 to 80 as reported by ClinicalTrials.gov.